Recovering Access to Primary Care

Debate between Michael Fabricant and Steve Barclay

Tuesday 9th May 2023 Commons Chamber

[Steve Barclay]

There seems to be a slightly confused response from the Opposition. They challenge this announcement on the grounds that they are not happy with it, and in the same breath claim that it is part of Labour’s plan or a step in the right direction. They need to make up their mind.

As I said in response to two earlier questions, it is for the integrated care boards to adopt estate strategies in their areas. Not all decisions about estates should be made centrally. However, one of the changes that we are setting centrally involves embracing more modern methods of construction and a more modular approach. The unit cost of that approach is much lower, and when the level of confidence is higher, the contingency cost is much lower as well. So we are changing the way in which we build our estate, but the estate strategy is an issue for the ICBs.

[Michael Fabricant (Lichfield) (Con)]

As the hon. Member for Coventry North West (Taiwo Owatemi) will know, it takes five years to obtain a master of pharmacy degree and to become fully qualified. Training continues as pharmacists continue in their work, so they are a valuable resource, and I welcome the statement. As my right hon. Friend the Secretary of State will know, in France, for instance, where it costs €26.50 to see a GP, most people would choose to see a pharmacist first, but is he sure that by taking pressure off general practices, he will not overwhelm pharmacists such as mine in Lichfield and Burntwood?

[Steve Barclay]

My hon. Friend is right to draw attention to the practice in other countries, and the fact that patients are very happy to visit pharmacists when that is more appropriate for the treatment that they are using. That is what the Pharmacy First strategy and the learning of lessons are all about, although we must also think about how to mitigate some of the risks connected with antimicrobial resistance. In the context of the impact on pharmacy, I refer my hon. Friend to what has been said by those in the sector. This is a move that they have called for and have now welcomed, and it responds very much to our discussions with pharmacists who have said that they can do more and are keen to do more, but need the funding to enable them to do so—which is what Pharmacy First delivers.

Oral Answers

Debate between Michael Fabricant and Steve Barclay

Tuesday 25th April 2023 Commons Chamber

[Steve Barclay]

I am always happy to praise the brilliant work of clinicians up and down the NHS, who do a formidable job. Given the huge scale of the backlogs we face as a consequence of the pandemic, it is important that we not only use the full capacity available within the NHS, empowering patients through patient choice and technologies such as the NHS app to better enable that, but maximise the capacity in the independent sector.

[Michael Fabricant (Lichfield) (Con)]

T7. Following the excellent television campaign on bowel cancer, which by the way got me to take a test, can I now ask that we have a similar campaign to talk about the importance of pharmacists? If people consult pharmacists rather than their GPs on occasion, it will take the pressure off general practices.

[Steve Barclay]

My hon. Friend makes a brilliant point, and that is something that we are committed to doing. There is a huge amount of expertise within the pharmacy network, which is why we are looking, through technology such as the NHS app, at how we can better enable people to get the right care from the right place at the right time. Quite often, that is not by seeing the GP, but it might be by seeing those in additional roles in primary care or going to a pharmacist who can offer the right services.

Oral Answers to Questions

Debate between Michael Fabricant and Steve Barclay

Tuesday 1st November 2022 Commons Chamber

[Michael Fabricant (Lichfield) (Con)]

1. Whether he supports the continuity of care and long-term relationship between a GP and their patients.

[The Secretary of State for Health and Social Care (Steve Barclay)]

The recent Health and Social Care Committee report rightly highlights the importance of continuity of care, recognising that there is sometimes a trade-off between speed of access and continuity of care.

[Michael Fabricant]

I welcome my right hon. Friend back to the Front Bench in this position; it is great to see him there. Investigations in the United States and in Australia show that if there is a close relationship between a patient and one specific general practitioner, the outcomes are better in terms of both morbidity and visits to A&E. What can the Government do to encourage that practice, and what is the Government’s view of that practice?

[Steve Barclay]

My hon. Friend raises an important point. If one looks at the GP survey of patients, around two in five have a GP that they would like to have continuity of care with, and more than one third of those say that they see them a lot of the time or always. It is more pertinent with complex cases, where that continuity of care adds most value, as opposed to patients who want speed of access on an isolated incident.

Oral Answers to Questions

Debate between Michael Fabricant and Steve Barclay

Thursday 16th May 2019 Commons Chamber

[Michael Fabricant (Lichfield) (Con)]

15. What recent assessment he has made of the merits of continued co-operation with the EU on security after the UK leaves the EU; and if he will make a statement.

[The Secretary of State for Exiting the European Union (Stephen Barclay)]

Last week, I was in Sibiu, where I made clear that we face common and evolving threats to European security. Those threats demand close co-operation and the UK has a leading role to play in that.

[Michael Fabricant]

My right hon. Friend will know that the Bundesnachrichtendienst has already made it absolutely clear that the United Kingdom is one of the biggest intelligence services in the world and a member of Five Eyes and that Europe is dependent on the United Kingdom for intelligence. We also wish to co-operate with them. Does that not make complete nonsense of what some Opposition Members say—that if we left the EU, without a deal or otherwise, the EU would not continue to co-operate with us for its own benefit?

[Stephen Barclay]

My hon. Friend is absolutely right that there is a shared interest between the UK and the European Union in close collaboration on security. He is right that the UK is the only European member of the Five Eyes intelligence network and that we are the only EU country that contributes both the NATO 2% and the overseas aid 0.7% commitments. It is in both sides’ interests to work closely on our shared challenges, because many of those challenges lie beyond Europe.